drugset

drugset / Trial / NCT00127153

A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

NCT00127153 ↗

Phase 3 Completed 130 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to evaluate the safety, tolerability, and immunogenicity of an investigational pneumococcal vaccine in healthy adults.

Timeline

Start: 2005-03
Primary completion: 2005-05
Completion: 2005-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pneumovax 23	Vaccine	—	—

Indications